Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narmeen S Rashid

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical & Experimental Metastasis|March 6, 2021
Breast cancer liver metastasis: current and future treatment approachesNarmeen S Rashid, Jacqueline M Grible, Charles V Clevenger, et al.
Clinical Genitourinary Cancer|February 25, 2025
Activity of 177Lu-PSMA-617 in Patients With Advanced Prostate Cancer and Brain MetastasesNarmeen S Rashid, Avina Rami, Min Lang, et al.
Clinical Genitourinary Cancer|March 27, 2026
Monitoring of Disease in Patients Receiving <sup>177</sup>LU-PSMA-617 Therapy in Routine PracticeNarmeen S Rashid, Caiwei Zhong, Wanling Xie, et al.
Journal of Neuro-Oncology|April 15, 2025
Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosisNarmeen S Rashid, Nayan Lamba, Paul J Catalano, et al.
Translational Oncology|October 10, 2021
Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancerNarmeen S Rashid, Nicole S Hairr, Graeme Murray, et al.
Breast Cancer Research and Treatment|October 5, 2024
Intracranial outcomes following neurosurgical resection in patients with brain metastases secondary to HER2-positive breast cancer versus other subtypesNarmeen S Rashid, Nayan Lamba, Paul J Catalano, et al.
EMBO Molecular Medicine|February 15, 2021
Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodiesTanmoy Mondal, Gururaj N Shivange, Rachisan Gt Tihagam, et al.
Scientific Reports|April 3, 2023
Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Scientific Reports|December 17, 2024
Author Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Scientific Reports|May 10, 2023
Publisher Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical & Experimental Metastasis|March 6, 2021
Breast cancer liver metastasis: current and future treatment approachesNarmeen S Rashid, Jacqueline M Grible, Charles V Clevenger, et al.
Clinical Genitourinary Cancer|February 25, 2025
Activity of 177Lu-PSMA-617 in Patients With Advanced Prostate Cancer and Brain MetastasesNarmeen S Rashid, Avina Rami, Min Lang, et al.
Clinical Genitourinary Cancer|March 27, 2026
Monitoring of Disease in Patients Receiving <sup>177</sup>LU-PSMA-617 Therapy in Routine PracticeNarmeen S Rashid, Caiwei Zhong, Wanling Xie, et al.
Journal of Neuro-Oncology|April 15, 2025
Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosisNarmeen S Rashid, Nayan Lamba, Paul J Catalano, et al.
Translational Oncology|October 10, 2021
Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancerNarmeen S Rashid, Nicole S Hairr, Graeme Murray, et al.
Breast Cancer Research and Treatment|October 5, 2024
Intracranial outcomes following neurosurgical resection in patients with brain metastases secondary to HER2-positive breast cancer versus other subtypesNarmeen S Rashid, Nayan Lamba, Paul J Catalano, et al.
EMBO Molecular Medicine|February 15, 2021
Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodiesTanmoy Mondal, Gururaj N Shivange, Rachisan Gt Tihagam, et al.
Scientific Reports|April 3, 2023
Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Scientific Reports|December 17, 2024
Author Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Scientific Reports|May 10, 2023
Publisher Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Pageof 2